NYSE - Nasdaq Real Time Price USD

Newmont Corporation (NEM)

Compare
41.57 +0.66 (+1.61%)
At close: 4:00 PM EST
41.57 +0.01 (+0.02%)
After hours: 4:15 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 4.61B
Earnings 922M
Q4'23
Q1'24
Q2'24
Q3'24
-2B
0
2B
4B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

45.00
55.70 Average
41.57 Current
72.74 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 741516
Avg. Estimate 1.040.933.113.86
Low Estimate 0.880.782.843.15
High Estimate 1.221.153.34.7
Year Ago EPS 0.50.551.613.11

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 431616
Avg. Estimate 5.18B5.15B18.39B19.49B
Low Estimate 4.98B5.05B17.8B17.1B
High Estimate 5.35B5.25B19.79B22.41B
Year Ago Sales 3.96B4.02B11.81B18.39B
Sales Growth (year/est) 30.90%28.00%55.66%5.98%

Earnings History

CURRENCY IN USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.440.370.610.86
EPS Actual 0.50.550.720.81
Difference 0.060.180.11-0.05
Surprise % 13.50%50.63%17.82%-5.32%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 1.040.933.113.86
7 Days Ago 1.070.963.133.95
30 Days Ago 1.090.973.134.05
60 Days Ago 1.0113.053.76
90 Days Ago 0.980.953.013.73

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days ------1
Up Last 30 Days 2--41
Down Last 7 Days 1125
Down Last 30 Days 2237

Growth Estimates

CURRENCY IN USD NEMIndustrySectorS&P 500
Current Qtr. 108.20%----5.00%
Next Qtr. 69.54%----12.00%
Current Year 93.13%----2.10%
Next Year 23.99%----12.20%

Upgrades & Downgrades

Initiated CLSA: Underperform 11/29/2024
Maintains Raymond James: Outperform to Outperform 11/25/2024
Upgrade JP Morgan: Neutral to Overweight 11/19/2024
Downgrade UBS: Buy to Neutral 10/30/2024
Maintains Raymond James: Outperform to Outperform 10/25/2024
Downgrade Scotiabank: Sector Outperform to Sector Perform 10/25/2024

Related Tickers